Getinge

Board/Management Information • Aug 22, 2016

Press Release

Gothenburg 2016-08-22

Replacement of President & CEO Getinge Group: Joacim Lindoff appointed Acting President & CEO of Getinge Group

The Board of Directors of Getinge AB has decided to replace the President & CEO of the Getinge Group, which means that Getinges' President & CEO Alex Myers is leaving his position. The Board of Directors has appointed Joacim Lindoff as Acting President & CEO. Joacim is currently President of Getinge Surgical Workflows and a member of the Executive Team. The change will be effective as of today.

"The Board of Directors and Alex Myers have different views on the future direction of the Getinge Group and the board has therefore concluded that a replacement of the President & CEO is necessary, says Carl Bennet, Getinge's Chairman of the Board.

Joacim Lindoff has been with Getinge since 1999 and has experience from different senior leading positions within the Group. Joacim recently served as Executive Vice President of the business area Infection Control and has since January 1, 2016, headed up Getinge Surgical Workflows and is a member of the Executive Team.

The process to recruit a new President & CEO of the Getinge Group will commence immediately.

For more information, please contact: Kornelia Rasmussen, Head of Group Communications Phone: +46 (0)10 335 5810 E-mail: kornelia.rasmussen@getinge.com

Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge's unique customer offering mirrors the hospital's organization and value chain, and the solutions are used before, during and after the patients' hospital stay. Based on first-hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.